Good morning
The new Capital Ideas website is going live this Monday, September 17, 2018.
We'll email you your automatic log-in link tomorrow at 12 pm eastern time.
On Monday, you can use that link and your usual user name and password to sign in to the new website.
See the Daily Update at the bottom of this email for details on the new site, including the Portfolio Tracker!
CANADIAN ANALYSTS’ CALLS
INITIATIONS
Desjardins starts coverage with a "buy" and a target of $4.75 (Canadian), calling the company a "silver lining in the silver space". The stock closed at $3.20.
RBC is indicating it thinks the 17% downturn on the dollar store retailer's stock yesterday after weaker than expected sales is overdone. The analyst says DOL reported a "solid, in-line Q2", and maintains an "outperform" with a price target of $52, giving the shares a projected 12 month return of 21%.
Industrial Alliance maintains a "buy" and a target of $54.50, calling the sell-of an "overreaction".
But a lot of analysts have been caught flatfooted by Dollarama's miss. CIBC is far less impressed and cuts DOL to "neutral" and lowers the target to $46 from $59, due to what it sees as slower organic growth and profit margin expansion.
Desjardins cuts to "hold", drops the target to $45 from $59 and reduces the EPS estimates.
Barclays lowers DOL's target to $44 from $53.
Raymond James' target goes to $50 from $56.
TD downgrades to "hold" with a target of $49.
CIBC lifts the target to $8.25 from $7.50 and maintains an "outperform".
U.S. ANALYSTS’ CALLS
Wedbush starts at "outperform" with a $177 (U.S.) target.
Citi upgrades the REIT to "buy" and moves the target to $74 from $67.
Jeferies hikes the target to $114 from $99.
Stifel Nicolaus ups the target to $60 from $54.
STOCKS THAT MAY MOVE
Newstrike (TSXV:HIP) has approached four companies about a possible sale, according to BNN Bloomberg. The company, backed by the remaining members of the Tragically Hip, tried to sell itself to CanniMed several months ago but that was scuttled when Aurora swooped in to buy CanniMed.
Organigram Holdings (TSXV:OGI)has agreed to buy 50% of a $10 million(Canadian) private placement debenture offering by Eviana Health Corp.
iAnthus Capital Holdings (CAE:IAN) plans to raise $30 million in a bought deal financing through a syndicate led by GMP Securities, which will buy 4.5 million shares at $6.65 each, a discount to Thursday's close of $7.65.
Amazon.com (NASDAQ:AMZN) could be interested in buying the struggling Real hypermarket chain from German retailer Metro, according to a Sanford Bernstein analyst, who says the asset could be valued at about 1 billion euros.
With files from The Globe and Mail, Reuters and Bloomberg News.
MARKETS
TSX and U.S. equity futures are modestly higher with the U.S. and China making conciliatory noises, and as investors mull U.S. retail sales, consumer sentiment and industrial data.
The latest frenzy in the cannabis sector continues to die down with Tilray, as an example, down another 13% in pre-market trading after Politico reported that marijuana investors could be banned from entering the U.S.
CURRENCIES
The Canadian dollar is down a bit at $76.81 U.S.
Bitcoin is slightly lower at $6,458, according to CoinDesk, after a rocky week for cryptocurrencies.
COMMODITIES WHAT WE’RE READING
West Texas Intermediate is flat at $68.59 (U.S.) a barrel.
Gold is not budging either at $1,207.80 an ounce.
As mentioned, Saturday, we’ll send you a link that, on Monday, you can use to automatically log-in to our new website using the same username and password that you use now.
We want this transition process to be as easy and seamless as possible for you.
Any questions, concerns or problems, email us at: customercare@capitalideasresearch.com
New Website Features
Our new website is designed with our subscribers top of mind.
It’s clean-looking, streamlined and easy to navigate, and provides you with the top quality investment research, CEO interviews and podcasts you’ve come to expect to help you make informed decisions about where to invest your money.
Portfolio Tracker!
The most compelling feature on our new website the Portfolio Tracker, where you can create your own portfolio, make changes and check in any time to view your investments all in one convenient, easy-to-use place.
Videos
The new Capital Ideas website allows you to easily watch our latest videos with CEOs of innovative, growth companies.
It’s also a breeze to access the newest research-based investment ideas in the weekly Capital Ideas Digest, and get up-to-the-minute analyst initiations, upgrades and downgrades and stocks on the move in the daily Morning Note.
If you like to get drawn in by an audio experience, the Capital Ideas Radio podcast is just a click away on five diferent platforms, including Apple Podcasts and Stitcher.
Get ready for an improved and enjoyable experience on the new Capital Ideas website. Coming Monday!
Please look out for the email we’ll send you Saturday at 12 pm ET with your automatic log-in link.
Peter Hodson and Ryan Modesto of 5i Research are ofering a limited time 30-Day Free Trial to get access to all of their independent, conflictfree company reports.
Receive Capital Ideas’ insights and ideas by signing up as a premium member for just $25 a month.
Capital Ideas TV
Thursdays on YouTube at 7 pm ET, 4 pm PT.
Sundays on BNN Bloomberg at 9 pm ET, 6 pm PT.
Capital Ideas Digest
Tuesday’s at 7 pm ET, 4 pm PT.
Capital Ideas Radio
Anytime, anywhere.
Access, insight and ideas.
Have a great weekend!
Access, insight and ideas.
Have a great weekend!
Mark Bunting
Publisher,
Capital Ideas Media
